» Articles » PMID: 15835269

Dysferlin Interacts with Affixin (beta-parvin) at the Sarcolemma

Overview
Specialties Neurology
Pathology
Date 2005 Apr 20
PMID 15835269
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

The dysferlin gene is defective in Miyoshi myopathy (MM) and limb girdle muscular dystrophy type 2B (LGMD2B). Dysferlin is a sarcolemmal protein that is implicated in calcium-dependent membrane repair. Affixin (beta-parvin) is a novel, integrin-linked kinase-binding protein that is involved in the linkage between integrin and the cytoskeleton. Here we show that affixin is a dysferlin binding protein that colocalizes with dysferlin at the sarcolemma of normal human skeletal muscle. The immunoreactivity of affixin was reduced in sarcolemma of MM and LGMD2B muscles, although the total amount of the affixin protein was normal. Altered immunoreactivity of affixin was also observed in other muscle diseases including LGMD1C, where both affixin and dysferlin showed quite similar changes with a reduction of sarcolemmal staining with or without cytoplasmic accumulations. Colocalization of dysferlin and affixin was confirmed by immunofluorescence analysis using dysferlin-expressing C2 myoblasts. Wild-type and mutant dysferlin colocalized with endogenous affixin. The interaction of dysferlin and affixin was confirmed by immunoprecipitation study using normal human and mouse skeletal muscles. Using immunoprecipitation with deletion mutants of dysferlin, we have identified that C-terminal region of dysferlin is an apparent binding site for affixin. We also found N-terminal calponin homology domain of affixin as a binding site for dysferlin. Our results suggest that affixin may participate in membrane repair with dysferlin.

Citing Articles

Utilizing Spermatogenesis and Fertilization Mutants as a Model for Human Disease.

Perez S, Augustineli H, Marcello M J Dev Biol. 2025; 13(1).

PMID: 39982357 PMC: 11843878. DOI: 10.3390/jdb13010004.


Differential Expression of Long Noncoding RNAs in Murine Myoblasts After Short Hairpin RNA-Mediated Dysferlin Silencing In Vitro: Microarray Profiling.

Singhal R, Lukose R, Carr G, Moktar A, Gonzales-Urday A, Rouchka E JMIR Bioinform Biotechnol. 2024; 3(1):e33186.

PMID: 38935964 PMC: 11135227. DOI: 10.2196/33186.


The Dysferlinopathies Conundrum: Clinical Spectra, Disease Mechanism and Genetic Approaches for Treatments.

Anwar S, Yokota T Biomolecules. 2024; 14(3).

PMID: 38540676 PMC: 10968265. DOI: 10.3390/biom14030256.


Portrait of Dysferlinopathy: Diagnosis and Development of Therapy.

Bouchard C, Tremblay J J Clin Med. 2023; 12(18).

PMID: 37762951 PMC: 10531777. DOI: 10.3390/jcm12186011.


Immune cells and their related genes provide a new perspective on the common pathogenesis of ankylosing spondylitis and inflammatory bowel diseases.

Ding Y, Yang Y, Xue L Front Immunol. 2023; 14:1137523.

PMID: 37063924 PMC: 10101339. DOI: 10.3389/fimmu.2023.1137523.